Robert Weinstein Synaptogenix, Inc. (SNPX) insider trading activity

Robert Weinstein is Chief Financial Officer of Synaptogenix, Inc.. Currently has a direct ownership of 16,574 shares of SNPX, which is worth approximately $108,062. The most recent transaction as insider was on Oct 17, 2025, when has been sold 4,000 shares (Common Stock, par value $0.0001 per share) at a price of $7.23 per share, resulting in proceeds of $28,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.6K

56.74% 3M change

50.08% 12M change

Total Value Held $108,062

ROBERT WEINSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 17 2025	SELL Payment of exercise price or tax liability	$28,920 $7.23 p/Share	4,000 Reduced 19.44%	16,574 Common Stock, par valu...
Oct 17 2025	BUY Grant, award, or other acquisition	-	10,000 Added 32.71%	20,574 Common Stock, par valu...
Jun 30 2025	SELL Payment of exercise price or tax liability	$48,387 $7.85 p/Share	6,164 Reduced 36.83%	10,574 Common Stock, par valu...
Jun 30 2025	BUY Grant, award, or other acquisition	-	15,410 Added 47.93%	16,738 Common Stock, par valu...
Dec 16 2022	SELL Open market or private sale	$31,589 $1.17 p/Share	27,000 Reduced 44.85%	33,198 Common Stock, par valu...
Jul 13 2021	BUY Grant, award, or other acquisition	-	60,000 Added 49.92%	60,198 Common Stock, par valu...

Also insider at

XSPA

XpresSpa Group, Inc. Consumer Cyclical

Director

PMCB

PharmaCyte Biotech, Inc. Healthcare

Director